216 related articles for article (PubMed ID: 27178306)
1. Absence of CD4(+) T cell help generates corrupt CD8(+) effector T cells in sarcoma-bearing Swiss mice treated with NLGP vaccine.
Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Biswas J; Mallick A; Bose A; Baral R
Immunol Lett; 2016 Jul; 175():31-9. PubMed ID: 27178306
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic targeting of established sarcoma in Swiss mice by tumor-derived antigen-pulsed NLGP matured dendritic cells is CD8+ T-cell dependent.
Mallick A; Barik S; Ghosh S; Roy S; Sarkar K; Bose A; Baral R
Immunotherapy; 2014; 6(7):821-31. PubMed ID: 25290415
[TBL] [Abstract][Full Text] [Related]
3. Neem leaf glycoprotein promotes dual generation of central and effector memory CD8(+) T cells against sarcoma antigen vaccine to induce protective anti-tumor immunity.
Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Saha A; Dasgupta S; Barik S; Bose A; Baral R
Mol Immunol; 2016 Mar; 71():42-53. PubMed ID: 26851529
[TBL] [Abstract][Full Text] [Related]
4. Normalization of tumor microenvironment by neem leaf glycoprotein potentiates effector T cell functions and therapeutically intervenes in the growth of mouse sarcoma.
Barik S; Banerjee S; Mallick A; Goswami KK; Roy S; Bose A; Baral R
PLoS One; 2013; 8(6):e66501. PubMed ID: 23785504
[TBL] [Abstract][Full Text] [Related]
5. Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions.
Goswami S; Bose A; Sarkar K; Roy S; Chakraborty T; Sanyal U; Baral R
Vaccine; 2010 Feb; 28(5):1241-52. PubMed ID: 19969119
[TBL] [Abstract][Full Text] [Related]
6. Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma.
Mallick A; Barik S; Goswami KK; Banerjee S; Ghosh S; Sarkar K; Bose A; Baral R
PLoS One; 2013; 8(1):e47434. PubMed ID: 23326300
[TBL] [Abstract][Full Text] [Related]
7. NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions.
Ghosh T; Nandi P; Ganguly N; Guha I; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Baral R; Bose A
Stem Cell Res Ther; 2019 Sep; 10(1):296. PubMed ID: 31547863
[TBL] [Abstract][Full Text] [Related]
8. Neem leaf glycoprotein prevents post-surgical sarcoma recurrence in Swiss mice by differentially regulating cytotoxic T and myeloid-derived suppressor cells.
Sarkar M; Ghosh S; Bhuniya A; Ghosh T; Guha I; Barik S; Biswas J; Bose A; Baral R
PLoS One; 2017; 12(4):e0175540. PubMed ID: 28414726
[TBL] [Abstract][Full Text] [Related]
9. Neem leaf glycoprotein generates superior tumor specific central memory CD8
Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Saha A; Dasgupta S; Barik S; Bose A; Baral R
Vaccine; 2017 Aug; 35(34):4421-4429. PubMed ID: 28684164
[TBL] [Abstract][Full Text] [Related]
10. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
Hu HM; Winter H; Urba WJ; Fox BA
J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
[TBL] [Abstract][Full Text] [Related]
11. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
[TBL] [Abstract][Full Text] [Related]
12. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
Yoshizawa H; Chang AE; Shu SY
Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
[TBL] [Abstract][Full Text] [Related]
13. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
[TBL] [Abstract][Full Text] [Related]
14. Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: histological, biochemical and immunological perspectives.
Mallick A; Ghosh S; Banerjee S; Majumder S; Das A; Mondal B; Barik S; Goswami KK; Pal S; Laskar S; Sarkar K; Bose A; Baral R
Int Immunopharmacol; 2013 Jan; 15(1):73-83. PubMed ID: 23178577
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.
Young JW; Steinman RM
J Exp Med; 1990 Apr; 171(4):1315-32. PubMed ID: 2139102
[TBL] [Abstract][Full Text] [Related]
16. Sufficiency of the CD8+ T cell lineage to mount an effective tumoricidal response to syngeneic tumor-bearing novel class I MHC antigens.
Fan ST; Edgington TS
J Immunol; 1989 Dec; 143(12):4287-91. PubMed ID: 2531780
[TBL] [Abstract][Full Text] [Related]
17. Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine.
Kao JY; Zhang M; Chen CM; Pierzchala A; Chen JJ
Immunol Lett; 2006 May; 105(1):16-25. PubMed ID: 16388858
[TBL] [Abstract][Full Text] [Related]
18. Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response.
Sarkar K; Goswami S; Roy S; Mallick A; Chakraborty K; Bose A; Baral R
Int Immunopharmacol; 2010 Aug; 10(8):865-74. PubMed ID: 20472099
[TBL] [Abstract][Full Text] [Related]
19. Combined Photosensitization and Vaccination Enable CD8 T-Cell Immunity and Tumor Suppression Independent of CD4 T-Cell Help.
Varypataki EM; Hasler F; Waeckerle-Men Y; Vogel-Kindgen S; Høgset A; Kündig TM; Gander B; Halin C; Johansen P
Front Immunol; 2019; 10():1548. PubMed ID: 31333674
[TBL] [Abstract][Full Text] [Related]
20. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
